Marked dopaminergic cell loss subsequent to developmental, intranigral expression of glial cell line-derived neurotrophic factor

Experimental Neurology

Volumn 173, Issue 2, 2002, Pages 235-244

  Chun, Hong S ^a   Yoo, Myung S ^a   DeGiorgio, Lorraine A ^a   Volpe, Bruce T ^a   Peng, Diana ^a   Baker, Harriet ^a   Peng, Chu ^a   Son, Jin H ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Cell death; Dopaminergic neurons; GDNF; Neuroprotection; Noradrenergic neurons; Parkinson's disease; TH; Transgenic mouse

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; TYROSINE 3 MONOOXYGENASE;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL COUNT; CELL LOSS; DOPAMINERGIC SYSTEM; HYBRID GENE; LOCUS CERULEUS; MORPHOMETRICS; MOUSE; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SUBSTANTIA NIGRA; TRANSGENIC MOUSE;

EID: 0036178992     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.2001.7842     Document Type: Article

References (40)

1. GDNF prevents degeneration and promotes the phenotype of brain noradrenergic neurons in vivo
2. Selective vulnerability of late-generated dopaminergic neurons of the substantia nigra in weaver mutant mice
3. Ontogeny and distribution of glial cell line-derived neurotrophic factor (GDNF) mRNA in rat
4. Dopaminergic neurons protected from degeneration by GDNF gene therapy
5. Histological and temporal characteristics of nigral transneuronal degeneration after striatal injury
6. Protection by synergistic effects of adenovirus-mediated X-chromosome-linked inhibitor of apoptosis and glial cell line-derived neurotrophic factor gene transfer in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease
7. Induction of cell death by endogenous nerve growth factor through its p75 receptor
8. Neurotrophins induce death of hippocampal neurons via the p75 receptor
9. Functional recovery in parkinsonian monkeys treated with GDNF
10. Neuroprotective and neurorestorative properties of GDNF
11. Animal models of Parkinson's disease: An empirical comparison with the phenomenology of the disease in man
12. Expression of neurturin, GDNF, and GDNF family-receptor mRNA in the developing and mature mouse
13. Glial cell line-derived neurotrophic factor is essential for postnatal survival of midbrain dopamine neurons
14. Morphological alterations in the peripheral and central nervous systems of mice lacking glial cell line-derived neurotrophic factor (GDNF): Immunohistochemical studies
15. Differential regulation of trophic factor receptor mRNAs in spinal motoneurons after sciatic nerve transection and ventral root avulsion in the rat
16. Developmental cell death in dopaminergic neurons of the substantia nigra of mice
17. Migration of dopaminergic neurons in the embryonic mesencephalon of mice
18. Long-term rAAV-mediated gene transfer of GDNF in the rat Parkinson's model: Intrastriatal but not intranigral transduction promotes functional regeneration in the lesioned nigrostriatal system
19. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease
20. GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons
21. Implantation of encapsulated catecholamine and GDNF-producing cells in rats with unilateral dopamine depletions and parkinsonian symptoms
22. Striatal dopaminergic afferents concentrate in GDNF-positive patches during development and in developing intrastriatal striatal grafts
23. Immunohistochemical localization of glial cell line-derived neurotrophic factor family receptor alpha-1 in the rat brain: Confirmation of expression in various neuronal systems
24. 5′ Upstream DNA sequence of the rat tyrosine hydroxylase gene directs high-level and tissue-specific expression to catecholaminergic neurons in the central nervous system of transgenic mice
25. Renal and neuronal abnormalities in mice lacking GDNF
26. Cellular expression of GDNF mRNA suggests multiple functions inside and outside the nervous system
27. The time course of developmental cell death in phenotypically defined dopaminergic neurons of the substantia nigra
28. Neuronal GDNF expression in the adult rat nervous system identified by in situ hybridization
29. Regional and cell-specific expression of GDNF in rat brain
30. Early ontogeny of catecholaminergic cell lineage in brain and peripheral neurons monitored by tyrosine hydroxylase-lacZ transgene
31. Neuroprotection and neuronal differentiation studies using substantia nigra dopaminergic cells derived from transgenic mouse embryos
32. Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo
33. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo
34. Implantation of bioactive growth factor-secreting rods enhances fetal dopaminergic graft survival, out-growth density, and functional recovery in a rat model of Parkinson's disease
35. Delayed histopathological neuronal damage in the substantia nigra compacta (nucleus A9) after transient forebrain ischaemia
36. Brain-derived neurotrophic factor prevents the loss of nigral neurons induced by excitotoxic striatal-pallidal lesions
37. Expression of the proto-oncogene Ret, a component of the GDNF receptor complex, persists in human substantia nigra neurons in Parkinson's disease
38. Glial cell line-derived neurotrophic factor stimulates the morphological differentiation of cultured ventral mesencephalic calbindin- and calretinin-expressing neurons
39. Short-term GDNF treatment provides long-term rescue of lesioned nigral dopaminergic neurons in a rat model of Parkinson's disease